|
Thursday 10th December 2009, Novartis Inaugural Lecture Series:
An Introduction to the National Health Service
Portcullis House, Westminster. MacMillan Room, 1830-2030hrs
Speaker
Professor Calum Paton,
School of Public Policy,
Univeristy of Keele
This session is the first of three lectures for junior doctors and other healthcare trainees, outlining the scope and purpose of the National Health Service.
Drinks and refreshments will be provided.
There are a limited number of free tickets for this event, and it is open to non-members. Please email richard.pinder@conservativemedicine.org.uk to book your place.
This event is sponsored by an unrestricted educational grant from Novartis
Events for 2010
Thursday 14th January 2010, Novartis Inaugural Lecture Series:
Reform of the National Health Service: From Thatcher to Darzi
Portcullis House, Westminster. MacMillan Room, 1830-2030hrs
Speaker
Prof Chris Ham,
School of Social Policy, University of Birmingham
This session is the second of three lectures for junior doctors and other healthcare trainees, outlining changes to the NHS, and where it stands today.
Drinks and refreshments will be provided.
There are a limited number of free tickets for this event, and it is open to non-members. Please email richard.pinder@conservativemedicine.org.uk to book your place.
This event is sponsored by an unrestricted educational grant from Novartis
Tuesday 26th January 2010, Novartis Inaugural Lecture Series:
The Future of the National Health Service
Portcullis House, Westminster. MacMillan Room, 1830-2030hrs
Speaker
Rt Hon Andrew Lansley MP OBE,
Shadow Secretary of State for Health
This session is the final of three lectures for junior doctors and other healthcare trainees, outlining the future of the National Health Service.
Drinks and refreshments will be provided.
There are a limited number of free tickets for this event, and it is open to non-members. Please email richard.pinder@conservativemedicine.org.uk to book your place.
This event is sponsored by an unrestricted educational grant from Novartis
|
